PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Brimonidine D-tartrate, 98%
CAS No 71159-25mg
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 176,000¿ø
Æ÷Àå´ÜÀ§
Æ÷Àå´ÜÀ§





¡Ø È­Çиí : Brimonidine D-tartrate, 98%

 

¡Ø µî±Þ : APIs and Bioactives > AChR Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 25mg , 100mg , 1g

 

¡Ø È­ÇÐ½Ä : C15H16BrN5O6

 

¡Ø CAS # : [70359-46-5]

IDENTITY
CAS Registry #: [70359-46-5]
MDL Number: MFCD07773086
MF: C15H16BrN5O6
MW: 442.22
SPECIFICATIONS & PROPERTIES
Purity: 98%
Physical Form: Almost white powder
Melting Point: 212-216¡ÆC
Long-Term Storage:

 

Store at room temperature

Shipping: Not Regulated for Shipping

REVIEW

Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2). It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.

Risk Description(s)
R36/37/38: Irritating to eyes, respiratory system and skin

Safety Description(s)
S24/25: Avoid contact with skin and eyes.